Download PDF
Thromb Haemost 1969; 22(02): 234-239
DOI: 10.1055/s-0038-1651438
Originalarbeiten-Original Articles-Travaux Originaux
Schattauer GmbH

The Purification of Fibrinogen Degradation Products by Pevikon Block Electrophoresis

V. J Marder   1
1   Dr. Theodore H. Mendell Research Laboratory, Temple University School of Medicine. Philadelphia, Pa. 19140, USA
,
H. L James
1   Dr. Theodore H. Mendell Research Laboratory, Temple University School of Medicine. Philadelphia, Pa. 19140, USA
,
S Sherry
1   Dr. Theodore H. Mendell Research Laboratory, Temple University School of Medicine. Philadelphia, Pa. 19140, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

Summary

The use of Pevikon block electrophoresis for the purification of bulk quantities of the major end-products of plasmin digestion of fibrinogen has been described. Greater than 50% yields of Fragments D and E were obtained, each free of contamination with the other.

1 This work is supported by Grant # HE 12418 from the National Heart Institute, Bethesda, Maryland 20014, USA.


 

  • References

  • 1 Nussenzweig V, Seligmann M. Analyse, par des méthodes immunochimiques, de la dégradation par la plasmine du fibrinogène humain et de la fibrine, á différents stades. Rev. Hémat. 15: 451 1960;
    PubMedGoogle Scholar
  • 2 Nussenzweig V, Seligmann M, Pelmont J, Grabar P. Les produits de dégradation du fìbrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques. Ann. Inst. Pasteur 100: 377 1961;
    PubMedGoogle Scholar
  • 3 Marder V. J, Shulman N. R, Carroll W. R. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Trans. Assoc. Amer. Phys. 80: 156 1967;
    PubMedGoogle Scholar
  • 4 Marder V. J, Shidman N. R, Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J. biol. Chem. 244: 2111 1969;
    PubMedGoogle Scholar
  • 5 Müller-Eberhard H. J, Kunkel H. G. The carbohydrate of λ-globulin and myeloma proteins. J. exp. Med. 104: 253 1956;
    CrossrefPubMedGoogle Scholar
  • 6 Larrieu M.-J, Marder V. J, Inceman S. Effects of fibrinogen degradation products on platelets and coagulation. In: Diffuse Intravascular Clotting. Trans. Int. Comm. on Haemostasis and Thrombosis, 1965. Eds. Koller F, Streuli F. 215 F. K. Schattauer Verlag; Stuttgart: 1966
    Google Scholar
  • 7 Niléhn J.-E. Split products of fibrinogen after prolonged interaction with plasmin. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 89 1967;
    PubMedGoogle Scholar
  • 8 Jamieson G. A, Gajfney Jr. P. J. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen. Biochim. biophys. Acta (Amst.) 154: 96 1968;
    CrossrefPubMedGoogle Scholar
  • 9 Fletcher A. P, Alkjaersig N, Fischer S, Sherry S. The proteolysis of fibrinogen by plasmin : The indentification of thrombinclottable fibrinogen derivatives which polymerize abnormally. J. Lab. clin. Med. 68: 780 1966;
    PubMedGoogle Scholar
  • 10 Johnson A. J, Kline D. L, Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thrombos. Diathes. haemorrh. (Stuttg.) 21: 259 1969;
    PubMedGoogle Scholar
  • 11 Davis B. J. Disc electrophoresis. II. Method and application to human serum proteins. Ann. N. Y. Acad. Sci. 121: 404 1964;
    PubMedGoogle Scholar
  • 12 Salafsky B, Loomis T. A. Paper electrophoresis of fibrinogen and its products. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 155 1963;
    PubMedGoogle Scholar
  • 13 Scheidegger J. J. Une micro-méthode de l’immuno-électrophorèse. Int. Arch. Allergy 7: 103 1955;
    CrossrefPubMedGoogle Scholar
  • 14 Marder V. J. Immunologic structure of fibrinogen and its split products of plasmin degradation. Theoretical and clinical considerations. In: Fibrinogen. Ed. Laki Koloman. 339 Marcel Dekker, Inc.; New York: 1968
    Google Scholar